BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen J, He Q, Wu P, Fu J, Xiao Y, Chen K, Xie D, Zhang X. ZMYND8 expression combined with pN and pM classification as a novel prognostic prediction model for colorectal cancer: Based on TCGA and GEO database analysis. Cancer Biomark 2020;28:201-11. [PMID: 32224527 DOI: 10.3233/CBM-191261] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Fang Z, Xu S, Xie Y, Yan W. Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis. World J Surg Oncol 2021;19:13. [PMID: 33441161 DOI: 10.1186/s12957-020-02116-y] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
2 Gong S, Ye W, Liu T, Jian S, Liu W. The Development of Three-DNA Methylation Signature as a Novel Prognostic Biomarker in Patients with Colorectal Cancer. Biomed Res Int 2020;2020:3497810. [PMID: 33294438 DOI: 10.1155/2020/3497810] [Reference Citation Analysis]
3 Zhang X, Wang S, Nie RC, Qu C, Chen J, Yang Y, Cai M. Immune Microenvironment Characteristics of Urachal Carcinoma and Its Implications for Prognosis and Immunotherapy. Cancers (Basel) 2022;14:615. [PMID: 35158883 DOI: 10.3390/cancers14030615] [Reference Citation Analysis]
4 Fu L, Shi Z, Chen B. Deleted in lymphocytic leukemia 2 induces retinoic acid receptor beta promoter methylation and mitogen activated kinase-like protein activation to enhance viability and mobility of colorectal cancer cells. Bioengineered 2022;13:12847-62. [PMID: 35611845 DOI: 10.1080/21655979.2022.2076482] [Reference Citation Analysis]
5 Chen Y, Tsai YH, Tseng SH. Regulation of ZMYND8 to Treat Cancer. Molecules 2021;26:1083. [PMID: 33670804 DOI: 10.3390/molecules26041083] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Jie Y, Yang X, Chen W. Expression and gene regulation network of TYMS and BCL2L1 in colorectal cancer based on data mining. PeerJ 2021;9:e11368. [PMID: 34141464 DOI: 10.7717/peerj.11368] [Reference Citation Analysis]
7 Choi S, Lee KW, Koh HH, Park S, Yeo SY, Joh JW, Choi MS, Kim SH, Park CK, Ha SY. Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma. J Cancer Res Clin Oncol 2021;147:3517-34. [PMID: 34462784 DOI: 10.1007/s00432-021-03768-3] [Reference Citation Analysis]